Literature DB >> 7825486

Hyperinsulinaemia and Alzheimer's disease.

G Razay1, G K Wilcock.   

Abstract

Because the aetiology of Alzheimer's disease (AD) remains unclear, and fasting hyperinsulinaemia has been incriminated in several human diseases, we examined the relationship between AD, fasting plasma insulin, glucose, body mass index and waist: hip ratio in 24 men and 24 women aged 58-90 years of whom half had probable AD. AD patients were randomly selected from the Bristol Memory Disorders Clinic, while controls were chosen from patients' spouses and the local community. Women with AD, compared with controls, have higher plasma insulin (p = 0.04), higher glucose (p = 0.04), and higher body mass index (p = 0.01). Similar differences were present in men but were not statistically significant except for body mass index (p = 0.03). We conclude that patients with AD have hyperinsulinaemia and insulin resistance, and this may be secondary to being overweight but a causal relationship cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7825486     DOI: 10.1093/ageing/23.5.396

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  42 in total

Review 1.  The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment.

Authors:  G Stennis Watson; Suzanne Craft
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 2.  Cardiovascular risk factors and Alzheimer's disease.

Authors:  José A Luchsinger; Richard Mayeux
Journal:  Curr Atheroscler Rep       Date:  2004-07       Impact factor: 5.113

Review 3.  Obesity, insulin resistance, and Alzheimer's disease.

Authors:  Kerry L Hildreth; Rachael E Van Pelt; Robert S Schwartz
Journal:  Obesity (Silver Spring)       Date:  2012-02-07       Impact factor: 5.002

Review 4.  Is Glucagon-like peptide-1, an agent treating diabetes, a new hope for Alzheimer's disease?

Authors:  Lin Li
Journal:  Neurosci Bull       Date:  2007-01       Impact factor: 5.203

Review 5.  Estrogen: a master regulator of bioenergetic systems in the brain and body.

Authors:  Jamaica R Rettberg; Jia Yao; Roberta Diaz Brinton
Journal:  Front Neuroendocrinol       Date:  2013-08-29       Impact factor: 8.606

Review 6.  Neurodegenerative disease and obesity: what is the role of weight loss and bariatric interventions?

Authors:  Hutan Ashrafian; Leanne Harling; Ara Darzi; Thanos Athanasiou
Journal:  Metab Brain Dis       Date:  2013-05-08       Impact factor: 3.584

7.  Aging-related correlation of insulin-degrading enzyme with gamma-secretase-generated products involving insulin and glucose levels in transgenic mice.

Authors:  Dae Y Hwang; Jung S Cho; Chuel K Kim; Sun B Shim; Seung W Jee; Su H Lee; Su J Seo; Joon Y Cho; Seok H Lee; Yong K Kim
Journal:  Neurochem Res       Date:  2005-09       Impact factor: 3.996

8.  L-arginine and Alzheimer's disease.

Authors:  Jing Yi; Laura L Horky; Avi L Friedlich; Ying Shi; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

Review 9.  Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective.

Authors:  José Alejandro Luchsinger
Journal:  Eur J Pharmacol       Date:  2008-03-04       Impact factor: 4.432

10.  Insulin and IGF-I prevent brain atrophy and DNA loss in diabetes.

Authors:  Predrag Serbedzija; James E Madl; Douglas N Ishii
Journal:  Brain Res       Date:  2009-09-23       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.